Fulcrum Therapeutics (FULC) on Saturday reported positive initial results from the ongoing 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease. “We are highly ...

CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve ...

The latest price target for Fulcrum Therapeutics (NASDAQ:FULC) was reported by Truist Securities on December 11, 2025. The analyst firm set a price target for $18.00 expecting FULC to rise to within ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to ...

Join us for an exclusive webinar where we unveil our new Python API designed to streamline trading as a price taker in FX Options. Whether you are a seasoned quant or trader looking to incorporate ...

FastAPI and AIOHTTP deliver speed and real-time response for modern applications. DRF remains a secure and reliable choice for enterprise-level projects. Lightweight frameworks like Flask, Hug, and ...

PLYMOUTH, Minn. — When not treated or managed correctly, chronic pain can take over a person's life, making it hard to enjoy normal things many take for granted. Fulcrum Health, Inc. is taking steps ...

Fulcrum says its new Soniq 42 wheels “maximise comfort” thanks to their FF80 carbon lamination rims, while the sawtooth rim profile optimises aerodynamics and stability. These features are a ...

Plymouth-based medical benefits organization Fulcrum Health is launching a mobile clinic to deliver non-pharmacological treatments like acupuncture, massage and physical therapy to underserved ...

Fulcrum Therapeutics (NASDAQ:FULC) fell ~10% on Tuesday after the company posted data from a late-stage study of its lead candidate, Pociredir, in sickle cell disease, along with second quarter ...